Offered advanced screenings throughout February to support early detection and prevention of heart disease....
Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation ...
The non-exclusive license and supply deal aims to enhance mRNA manufacturing efficiency and scalability....
Susvimo becomes the only FDA-approved therapy offering continuous drug delivery for diabetic eye disease....
Strategic move aims to accelerate advancements in cancer detection and drug development....
Successful results from the pivotal study pave the way for regulatory submissions in lung cancer screening....
The Middle East's medtech and diagnostics sector is undergoing a dynamic transformation, fuelled by rapid technological advancements and strategic healthcare investments. This burgeoning industry is poised for significant growth, driven by a convergence of regional and global trends. As the region continues to embrace innovation and prioritise healthcare, it is well on its way to becoming a global hub for medtech and diagnostics, attracting investment, fostering collaboration, and driving advanc...
Asia accounts for nearly half of global cancer cases, making it a major health concern. Recognising the promise of precision oncology, governments across the region have initiated efforts to drive advancements in this space. Let's take a closer look at the progress being made in precision oncology in the Asia Pacific region....
The new test panel aims to revolutionize traumatic brain injury detection with advanced diagnostic capabilities....
JOURNAVX™ introduces a first-in-class approach to managing moderate-to-severe acute pain, offering an alternative to traditional opioid therapies....
